References
- An Indian Council of Medical Research Task Force Study. Indian Council of Medical Research, New Delhi 1993 (http://www.icmr.nic.in)
- Saxcena A, Phadke SR. Thalassaemia control by carrier screening: The Indian scenario. Curr Sci. 2002;83(3):291–295
- Telfer P, Coen PG, Christou S, et al. Survival of medically treated thalassaemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Haematologica. 2006;91(9):1187–1192
- Modell B, Khan M, Darlinson M. Survival in β thalassaemia major in the UK: Data from the UK Thalassaemia Register. Lancet. 2000; 355(9220):2051–2052
- Malik S, Chatterjee C, Mandal PK, et al. Expenditure to treat thalassaemia: An experience at a tertiary care hospital in India. Iran J Public Health. 2010;39(1):78–84
- Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet. 1991;1(8216):369–370
- Petrou M, Modell B. Prenatal screening for haemoglobin disorders. Prenat Diagn. 1995;15(13):1275–1295
- Mohanti D, Colah R, Gorakshakar A. Jay Vigyan S and T mission project on community control of thalassaemia syndromes – Awareness, screening, genetic counselling and prevention. A national multicentric Task Force Study of the Indian Council of Medical Research (ICMR), New Delhi, 2008 (ISBN-81-901853-0-1) (http://www.icmr.nic.in)
- Dormandy E, Gulliford M, Bryan S, et al. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: Cluster randomised trial. BMJ. 2010;341:c5132. doi: 10.1136/bmj.c5132
- National Health Service Sickle Cell and Thalassaemia Screening Programme: Standards for linked antenatal and newborn screening programme; 2006 (http://sct.screening.nhs.uk/cms.php?folder=2493)
- Modell B, Harris R, Lane B, et al. Informed choice in genetic screening for thalassaemia during pregnancy: Audit from a national confidential enquiry. BMJ. 2000;320(7231):337–341
- Greengross P, Hickman M, Gill M, et al. Outcomes of universal antenatal screening for haemoglobinopathies. J Med Screen. 1999;6(1):3–10
- Gajra B, Chakraborti S, Sengupta B. Prenatal diagnosis of thalassaemias. Int J Hum Genet. 2002;2(3):173–178
- Modell B, Ward RHT, Fairweather DVI. Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major. BMJ. 1980;280(628):1347–1350
- Cao A, Furbetta M, Galanello R, et al. Prevention of homozygous β-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Am J Hum Genet. 1981;33(4):592–605
- Wong LP, George E, Tan J. Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population. BMC Public Health. 2011;11:193. doi: 10.1186/1471-2458-11-193
- Modell B, Petrou M, Layton M, et al. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: The first 20 years. BMJ. 1997;315(7111):779–784
- Fairweather DVI, Ward RHT, Modell B. Obstetric aspects of midtrimester fetal blood sampling by needling or fetoscopy. Br J Obstet Gynaecol. 1980;87(2):87–99